ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
CNS Pharmaceuticals Inc

CNS Pharmaceuticals Inc (CNSP)

3,71
0,09
(2,49%)
Geschlossen 22 März 9:00PM
3,79
0,08
(2,16%)
Nach Börsenschluss: 12:52AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
3,79
Gebot
3,63
Fragen
3,79
Volumen
106.675
3,51 Tagesbereich 3,80
2,00 52-Wochen-Bereich 975,00
Marktkapitalisierung
Handelsende
3,62
Handelsbeginn
3,51
Letzte Trade
1
@
3.79
Letzter Handelszeitpunkt
Finanzvolumen
US$ 393.389
VWAP
3,6877
Durchschnittliches Volumen (3 Mio.)
26.751.379
Ausgegebene Aktien
1.499.251
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,30
Gewinn pro Aktie (EPS)
-12,57
Erlöse
-
Nettogewinn
-18,85M

Über CNS Pharmaceuticals Inc

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of ... CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Carson City, Nevada, USA
Gegründet
-
CNS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CNSP. The last closing price for CNS Pharmaceuticals was US$3,62. Over the last year, CNS Pharmaceuticals shares have traded in a share price range of US$ 2,00 to US$ 975,00.

CNS Pharmaceuticals currently has 1.499.251 shares in issue. The market capitalisation of CNS Pharmaceuticals is US$5,43 million. CNS Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.30.

CNSP Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.9834.87544483992.814.62.733013653.52417725CS
40.4914.84848484853.34.623691112.76194921CS
12-2.08-35.43441226585.879.52267513796.00604357CS
26-3.66-49.12751677857.4518.4952202225086.30366698CS
52-920.71-99.590048675924.597521161162215.65429552CS
156-28496.21-99.98670175442850033562.5243163981070.72576524CS
260-262496.21-99.99855619052625004215002288623915302.218824CS

CNSP - Frequently Asked Questions (FAQ)

What is the current CNS Pharmaceuticals share price?
The current share price of CNS Pharmaceuticals is US$ 3,79
How many CNS Pharmaceuticals shares are in issue?
CNS Pharmaceuticals has 1.499.251 shares in issue
What is the market cap of CNS Pharmaceuticals?
The market capitalisation of CNS Pharmaceuticals is USD 5,43M
What is the 1 year trading range for CNS Pharmaceuticals share price?
CNS Pharmaceuticals has traded in the range of US$ 2,00 to US$ 975,00 during the past year
What is the PE ratio of CNS Pharmaceuticals?
The price to earnings ratio of CNS Pharmaceuticals is -0,3
What is the reporting currency for CNS Pharmaceuticals?
CNS Pharmaceuticals reports financial results in USD
What is the latest annual profit for CNS Pharmaceuticals?
The latest annual profit of CNS Pharmaceuticals is USD -18,85M
What is the registered address of CNS Pharmaceuticals?
The registered address for CNS Pharmaceuticals is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703
What is the CNS Pharmaceuticals website address?
The website address for CNS Pharmaceuticals is www.cnspharma.com
Which industry sector does CNS Pharmaceuticals operate in?
CNS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SGLYSingularity Future Technology Ltd
US$ 1,6799
(143,43%)
30,76M
WINVWinVest Acquisition Corporation
US$ 25,00
(107,30%)
463
VVPRVivoPower International PLC
US$ 1,2899
(52,13%)
65,08M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
GLTOGalecto Inc
US$ 6,00
(44,93%)
10,71M
YHCLQR House Inc
US$ 0,40
(-82,38%)
38,32M
KZIAKazia Therapeutics Ltd
US$ 0,9759
(-80,02%)
55,66k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
TCBPTC BioPharm Holdings PLC
US$ 0,5046
(-67,23%)
5,9M
SOWGSow Good Inc
US$ 1,53
(-44,36%)
698,02k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
NVDANVIDIA Corporation
US$ 117,70
(-0,70%)
264,42M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,03
(10,66%)
175,77M
HOLOMicroCloud Hologram Inc
US$ 1,00
(32,36%)
141,98M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock